Deepinder Goyal Reveals 'Temple': A Brain-Flow Device Born from a Gravity Theory

Zomato's founder Deepinder Goyal has given us a first look at his new product called 'Temple'. It's a small wearable device designed to monitor blood flow in your brain. This gadget actually came from his personal research into a pretty wild idea about gravity affecting how we age. He's been testing it himself and thinks it could be really useful for health, even if his gravity theory doesn't pan out.

Key Points: Zomato's Deepinder Goyal Unveils Brain Blood Flow Device Temple

  • Goyal shared a teaser of the small wearable gadget on his Instagram with the caption "Getting there"
  • The device is linked to his 'Gravity Ageing Hypothesis', which suggests gravity may affect human lifespan
  • He has used Temple for a year and believes it could be a key global health tool
  • Goyal denies the unconventional theory was created just to market the new device
2 min read

Deepinder Goyal unveils teaser of 'Temple', a brain-flow device

Zomato founder Deepinder Goyal unveils 'Temple', a wearable device to monitor brain blood flow, born from his research into a novel gravity-ageing hypothesis.

"Temple is an ‘experimental device’ designed to measure brain blood flow accurately, in real time, and on a continuous basis. - Deepinder Goyal"

New Delhi, Dec 7

Deepinder Goyal, founder and CEO of Zomato’s parent company Eternal, on Sunday shared a first look at his new product, a brain blood flow monitoring device called ‘Temple’.

He posted a short teaser on Instagram with the caption “Getting there,” giving users a glimpse of the small wearable gadget.

The device has sparked curiosity ever since Goyal was seen wearing a tiny golden sensor on the right side of his forehead.

Many users wondered what it was, prompting him to explain its purpose in an earlier LinkedIn post.

Goyal said that Temple is an ‘experimental device’ designed to measure brain blood flow accurately, in real time, and on a continuous basis.

He said the device was created while he was researching his recently discussed ‘Gravity Ageing Hypothesis’.

Last month, Goyal shared a series of posts outlining this “scientific yet unconventional” idea. He suggested that gravity could directly affect how humans age.

In his words, he was sharing the theory not as a CEO but as someone curious enough to follow a strange scientific path.

He noted that while Newton defined gravity and Einstein described how it bends spacetime, he believes gravity may also shorten human lifespan.

Goyal said he is studying connections between three factors: how standing upright slightly reduces blood flow to the brain, how sensitive certain brain regions like the hypothalamus and brainstem are to small changes in circulation, and how these regions control the ageing process.

According to him, these links could open a new understanding of how ageing works.

Goyal revealed that he has been using the Temple device for a year and feels it has the potential to become an important global health tool.

He pointed out that brain blood flow is already considered a key biomarker for ageing, longevity and cognitive health.

Because of that, he believes Temple remains useful even if his gravity-based ageing theory proves incorrect.

Addressing speculation that the hypothesis was simply a strategy to promote the device, Goyal denied any such intention.

He said Temple would be a “small, cute company” compared to Eternal and made it clear that he would never risk customers’ trust for marketing.

He emphasised that the Gravity Ageing Hypothesis was not created to sell the device, but emerged from genuine scientific curiosity.

- IANS

Share this article:

Reader Comments

R
Rohit P
Gravity affecting ageing? Sounds a bit out there, yaar. But I respect Deepinder for putting his curiosity out there. The device itself seems more practical. Let's see the data.
A
Aman W
First Zomato, now this. Our Indian entrepreneurs are truly thinking big and venturing into deep science. This is the kind of moonshot thinking we need. Proud moment!
S
Sarah B
While the hypothesis is unconventional, the core product—a wearable biomarker monitor—has clear potential. It's smart to separate the device's utility from the theory. Cautiously optimistic.
V
Vikram M
I appreciate his transparency about it being experimental. But as a consumer, I have a respectful criticism: please ensure rigorous peer-reviewed validation before any market launch. Trust is everything.
K
Kavya N
My grandfather has early signs of cognitive decline. If this device can help monitor something related to brain health easily and non-invasively, it would be a godsend for families like ours. 🙏

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50